In Vitro Evaluation of a New Aminoglycoside Derivative of Kanamycin, BB-KA: a Comparison with Tobramycin and Gentamycin
AUTOR(ES)
Ries, Kristen
RESUMO
Against more than 90% of 200 bacterial strains tested in vitro, the inhibitory concentration of gentamicin and tobramycin was 3.1 μg/ml and that of BB-K 8, a new semisynthetic aminoglycoside derivative of kanamycin, was 6.3 μg/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444449Documentos Relacionados
- In Vitro Evaluation of a New Aminoglycoside Derivative of Kanamycin, a Comparison with Tobramycin and Gentamycin
- In Vitro Comparison of Four Aminoglycoside Antibiotics: Sisomicin, Gentamicin, Tobramycin, and BB-K8
- In Vitro Evaluation of Tobramycin, a New Aminoglycoside Antibiotic
- Comparative In Vitro Activity of Three Aminoglycosidic Antibiotics: BB-K8, Kanamycin, and Gentamicin
- Comparative Activity of Sisomicin, Gentamicin, Kanamycin, and Tobramycin
